Skip to main content
Erschienen in: Journal of Clinical Immunology 1/2007

01.01.2007

Rosmarinic Acid Induces Apoptosis of Activated T Cells from Rheumatoid Arthritis Patients via Mitochondrial Pathway

verfasst von: YUN-GYOUNG HUR, CHANG-HEE SUH, SUNGJOO KIM, JONGHWA WON

Erschienen in: Journal of Clinical Immunology | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

T cells play an important role in the initiation and the progression of rheumatoid arthritis (RA) and depletion of potentially pathogenic T cells was suggested as an important therapeutic protocol. We determined if rosmarinic acid (RosA), known as a secondary metabolite from herbal plants, had apoptotic activity toward T cells from RA patients and further verified target T-cell subsets. CD3+CD25+ activated T-cell subsets from most of the RA patients displayed significantly higher apoptosis rates than did the PBMCs and total CD3+ T cells. Furthermore, activated and effector CD4+ T cells, including CD4+CD25+ and CD4+CD45RO+ T cells, had a tendency of being more susceptible to RosA-induced apoptosis than that of resting and naïve T-cell subsets. RosA induced the release of cytochrome c from mitochondria and the blockage of mitochondrial depolarization inhibited apoptosis. Taken together, these results suggest that RosA induces apoptosis of activated T-cell subsets from RA patients via a mitochondrial pathway.
Literatur
2.
Zurück zum Zitat VanderBorght A, Geusens P, Raus J, Stinissen P: The autoimmune pathogenesis of rheumatoid arthritis: Role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum 31:160–175, 2001PubMedCrossRef VanderBorght A, Geusens P, Raus J, Stinissen P: The autoimmune pathogenesis of rheumatoid arthritis: Role of autoreactive T cells and new immunotherapies. Semin Arthritis Rheum 31:160–175, 2001PubMedCrossRef
3.
Zurück zum Zitat Granholm NA, Cavallo T: Autoimmunity, polyclonal B-cell activation and infection. Lupus 1:63–74, 1992PubMed Granholm NA, Cavallo T: Autoimmunity, polyclonal B-cell activation and infection. Lupus 1:63–74, 1992PubMed
4.
Zurück zum Zitat Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS: HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32:15–21, 1989PubMed Nepom GT, Byers P, Seyfried C, Healey LA, Wilske KR, Stage D, Nepom BS: HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum 32:15–21, 1989PubMed
5.
Zurück zum Zitat Gumanovskaya ML, Myers LK, Rosloniec EF, Stuart JM, Kang AH: Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells. Immunology 97:466–473, 1999PubMedCrossRef Gumanovskaya ML, Myers LK, Rosloniec EF, Stuart JM, Kang AH: Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells. Immunology 97:466–473, 1999PubMedCrossRef
6.
Zurück zum Zitat Kadowaki KM, Matsuno H, Tsuji H, Tunru I: CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol 97:212–218, 1994PubMedCrossRef Kadowaki KM, Matsuno H, Tsuji H, Tunru I: CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice. Clin Exp Immunol 97:212–218, 1994PubMedCrossRef
7.
Zurück zum Zitat Spargo LD, Cleland LG, Wing SJ, Hawkes JS, Mayrhofer G: Characterization of thoracic duct cells that transfer polyarthritis. Clin Exp Immunol 126:560–569, 2001PubMedCrossRef Spargo LD, Cleland LG, Wing SJ, Hawkes JS, Mayrhofer G: Characterization of thoracic duct cells that transfer polyarthritis. Clin Exp Immunol 126:560–569, 2001PubMedCrossRef
8.
Zurück zum Zitat Zhang HG, Yang P, Xie J, Liu Z, Liu D, Xiu L, Zhou T, Wang Y, Hsu HC, Mountz JD: Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice. J Immunol 168:4164–4172, 2002PubMed Zhang HG, Yang P, Xie J, Liu Z, Liu D, Xiu L, Zhou T, Wang Y, Hsu HC, Mountz JD: Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA/1j mice. J Immunol 168:4164–4172, 2002PubMed
9.
Zurück zum Zitat Tada Y, Nagasawa K, Ho A, Morito F, Ushiyama O, Suzuki N, Ohta H, Mak TW: CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 162:203–208, 1999PubMed Tada Y, Nagasawa K, Ho A, Morito F, Ushiyama O, Suzuki N, Ohta H, Mak TW: CD28-deficient mice are highly resistant to collagen-induced arthritis. J Immunol 162:203–208, 1999PubMed
10.
Zurück zum Zitat Nakashima T, Wada T, Penninger JM: RANKL and RANK as novel therapeutic targets for arthritis. Curr Opin Rheumatol 15:280–287, 2003PubMedCrossRef Nakashima T, Wada T, Penninger JM: RANKL and RANK as novel therapeutic targets for arthritis. Curr Opin Rheumatol 15:280–287, 2003PubMedCrossRef
11.
Zurück zum Zitat Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY: Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: Cross-talk between T cells and synovial fibroblasts. Arthritis Rheum 50:776–784, 2004PubMedCrossRef Cho ML, Yoon CH, Hwang SY, Park MK, Min SY, Lee SH, Park SH, Kim HY: Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: Cross-talk between T cells and synovial fibroblasts. Arthritis Rheum 50:776–784, 2004PubMedCrossRef
12.
Zurück zum Zitat Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, Ni L, Xu R, Hong J, Zhang JZ: Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060–1067, 2005PubMedCrossRef Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, Ni L, Xu R, Hong J, Zhang JZ: Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 115:1060–1067, 2005PubMedCrossRef
13.
Zurück zum Zitat Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304–309, 1999PubMedCrossRef Kong YY, Feige U, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304–309, 1999PubMedCrossRef
14.
Zurück zum Zitat Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963–970, 1999PubMedCrossRef Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, Miossec P: Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 42:963–970, 1999PubMedCrossRef
15.
Zurück zum Zitat Lubberts E, Van Den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, Van Den Berg WB: IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 170:2655–2662, 2003PubMed Lubberts E, Van Den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, Van Den Berg WB: IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol 170:2655–2662, 2003PubMed
16.
Zurück zum Zitat Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–6177, 2003PubMed Nakae S, Nambu A, Sudo K, Iwakura Y: Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 171:6173–6177, 2003PubMed
17.
Zurück zum Zitat Lubberts E, Koenders MI, Oppers-Walgreen B, Van Den Bersselaar L, Coenen-de Roo CJ, Joosten LA, Van Den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659, 2004PubMedCrossRef Lubberts E, Koenders MI, Oppers-Walgreen B, Van Den Bersselaar L, Coenen-de Roo CJ, Joosten LA, Van Den Berg WB: Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50:650–659, 2004PubMedCrossRef
18.
Zurück zum Zitat Ogawa Y, Ohtsuki M, Uzuki M, Sawai T, Onozawa Y, Nakayama J, Yonemura A, Kimura T, Matsuno H: Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells. Arthritis Rheum 48:3350–3358, 2003PubMedCrossRef Ogawa Y, Ohtsuki M, Uzuki M, Sawai T, Onozawa Y, Nakayama J, Yonemura A, Kimura T, Matsuno H: Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells. Arthritis Rheum 48:3350–3358, 2003PubMedCrossRef
19.
Zurück zum Zitat Al-Sereiti MR, Abu-Amer KM, Sen P: Pharmacology of rosmary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37:124–130, 1999PubMed Al-Sereiti MR, Abu-Amer KM, Sen P: Pharmacology of rosmary (Rosmarinus officinalis Linn.) and its therapeutic potentials. Indian J Exp Biol 37:124–130, 1999PubMed
20.
Zurück zum Zitat Kelm MA, Nair MG, Strasburg GM, DeWitt DL: Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 7:7–13, 2000PubMed Kelm MA, Nair MG, Strasburg GM, DeWitt DL: Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine 7:7–13, 2000PubMed
21.
Zurück zum Zitat Choy EH, Kingsley GH, Panayi GS: Monoclonal antibody therapy in rheumatoid arthritis. Br J Rheumatol 37:484–490, 1998PubMedCrossRef Choy EH, Kingsley GH, Panayi GS: Monoclonal antibody therapy in rheumatoid arthritis. Br J Rheumatol 37:484–490, 1998PubMedCrossRef
22.
Zurück zum Zitat Hur YG, Yun Y, Won J: Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction. J Immunol 172:79–87, 2004PubMed Hur YG, Yun Y, Won J: Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral T cells via mitochondrial pathway independent from Fas/Fas ligand interaction. J Immunol 172:79–87, 2004PubMed
23.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324, 1998 Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324, 1998
24.
Zurück zum Zitat Acuto O, Michel F: CD28-mediated co-stimulation: A quantitative support for TCR signalling. Nat Rev Immunol 3:939–951, 2003PubMedCrossRef Acuto O, Michel F: CD28-mediated co-stimulation: A quantitative support for TCR signalling. Nat Rev Immunol 3:939–951, 2003PubMedCrossRef
25.
Zurück zum Zitat Schmidt D, Goronzy JJ, Weyand CM: CD4+ CD7− CD28− T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97:2027–2037, 1996PubMed Schmidt D, Goronzy JJ, Weyand CM: CD4+ CD7− CD28− T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest 97:2027–2037, 1996PubMed
26.
Zurück zum Zitat Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, Mannarino E: CD4+CD28− T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109:2744–2748, 2004PubMedCrossRef Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, Marchesi S, Pirro M, Ragni F, Shoenfeld Y, Mannarino E: CD4+CD28− T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 109:2744–2748, 2004PubMedCrossRef
27.
Zurück zum Zitat Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J Immunol 161:1018–1025, 1998PubMed Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J Immunol 161:1018–1025, 1998PubMed
28.
Zurück zum Zitat Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347–1349, 1995PubMedCrossRef Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP: Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347–1349, 1995PubMedCrossRef
29.
Zurück zum Zitat Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969–976, 1994PubMedCrossRef Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969–976, 1994PubMedCrossRef
30.
Zurück zum Zitat Siegel RM, Chan FK, Chun HJ, Lenardo MJ: The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1:469–474, 2000PubMedCrossRef Siegel RM, Chan FK, Chun HJ, Lenardo MJ: The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat Immunol 1:469–474, 2000PubMedCrossRef
31.
Zurück zum Zitat Hoa TT, Hasunuma T, Aono H, Masuko K, Kobata T, Yamamoto K, Sumida T, Nishioka K: Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 23:1332–1337, 1996PubMed Hoa TT, Hasunuma T, Aono H, Masuko K, Kobata T, Yamamoto K, Sumida T, Nishioka K: Novel mechanisms of selective apoptosis in synovial T cells of patients with rheumatoid arthritis. J Rheumatol 23:1332–1337, 1996PubMed
32.
Zurück zum Zitat Chou CT, Yang JS, Lee MR: Apoptosis in rheumatoid arthritis—Expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 193:110–116, 2001PubMedCrossRef Chou CT, Yang JS, Lee MR: Apoptosis in rheumatoid arthritis—Expression of Fas, Fas-L, p53, and Bcl-2 in rheumatoid synovial tissues. J Pathol 193:110–116, 2001PubMedCrossRef
33.
Zurück zum Zitat Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A: JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411:77–82, 1997PubMedCrossRef Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A: JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: Implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411:77–82, 1997PubMedCrossRef
34.
Zurück zum Zitat Soden M, Hassan J, Scott DL, Hanly JG, Moriarty M, Whelan A, Feighery C, Bresnihan B: Lymphoid irradiation in intractable rheumatoid arthritis. Long-term follow-up of patients treated with 750 rads or 2,000 rads. Arthritis Rheum 32:523–530, 1989PubMed Soden M, Hassan J, Scott DL, Hanly JG, Moriarty M, Whelan A, Feighery C, Bresnihan B: Lymphoid irradiation in intractable rheumatoid arthritis. Long-term follow-up of patients treated with 750 rads or 2,000 rads. Arthritis Rheum 32:523–530, 1989PubMed
35.
Zurück zum Zitat Ueki Y, Nakamura H, Kanamoto Y, Miyazaki M, Yano M, Matsumoto K, Miyake S, Tominaga T, Tominaga M, Yamasaki S, Eguchi K: Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis. Ther Apher 5:455–461, 2001PubMedCrossRef Ueki Y, Nakamura H, Kanamoto Y, Miyazaki M, Yano M, Matsumoto K, Miyake S, Tominaga T, Tominaga M, Yamasaki S, Eguchi K: Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis. Ther Apher 5:455–461, 2001PubMedCrossRef
36.
Zurück zum Zitat Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, Kawakami M, Ohsuzu F: Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher 3:178–185, 1999PubMedCrossRef Hidaka T, Suzuki K, Matsuki Y, Takamizawa-Matsumoto M, Okada M, Ishizuka T, Kawakami M, Ohsuzu F: Changes in CD4+ T lymphocyte subsets in circulating blood and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis. Ther Apher 3:178–185, 1999PubMedCrossRef
37.
Zurück zum Zitat Herzog C, Walker C, Muller W, Rieber P, Reiter C, Riethmuller G, Wassmer P, Stockinger H, Madic O, Pichler WJ: Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmun 2:627–642, 1989PubMedCrossRef Herzog C, Walker C, Muller W, Rieber P, Reiter C, Riethmuller G, Wassmer P, Stockinger H, Madic O, Pichler WJ: Anti-CD4 antibody treatment of patients with rheumatoid arthritis: I. Effect on clinical course and circulating T cells. J Autoimmun 2:627–642, 1989PubMedCrossRef
38.
Zurück zum Zitat Kirkham BW, Pitzalis C, Kingsley GH, Chikanza IC, Sabharwal S, Barbatis C, Grahame R, Gibson T, Amlot PL, Panayi GS: Monoclonal antibody treatment in rheumatoid arthritis: The clinical and immunological effects of a CD7 monoclonal antibody. Br J Rheumatol 30:459–463, 1991PubMedCrossRef Kirkham BW, Pitzalis C, Kingsley GH, Chikanza IC, Sabharwal S, Barbatis C, Grahame R, Gibson T, Amlot PL, Panayi GS: Monoclonal antibody treatment in rheumatoid arthritis: The clinical and immunological effects of a CD7 monoclonal antibody. Br J Rheumatol 30:459–463, 1991PubMedCrossRef
39.
Zurück zum Zitat Keystone E: Treatments no longer in development for rheumatoid arthritis. Ann Rheum Dis 61:43–45, 2002 Keystone E: Treatments no longer in development for rheumatoid arthritis. Ann Rheum Dis 61:43–45, 2002
40.
Zurück zum Zitat Rep MH, van Oosten BW, Roos MT, Ader HJ, Polman CH, van Lier PA: Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. J Clin Invest 99:2225–2231, 1997PubMed Rep MH, van Oosten BW, Roos MT, Ader HJ, Polman CH, van Lier PA: Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. J Clin Invest 99:2225–2231, 1997PubMed
41.
Zurück zum Zitat Ruderman EM, Weinblatt ME, Thurmond LM, Pinkus GS, Gravallese EM: Synovial tissue response to treatment with Campath-1H. Arthritis Rheum 38:254–258, 1995PubMed Ruderman EM, Weinblatt ME, Thurmond LM, Pinkus GS, Gravallese EM: Synovial tissue response to treatment with Campath-1H. Arthritis Rheum 38:254–258, 1995PubMed
42.
Zurück zum Zitat Liu Z, Xu X, Hsu HC, Tousson A, Yang PA, Wu Q, Liu C, Yu S, Zhang HG, Mountz JD: CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 112:1332–1341, 2003PubMedCrossRef Liu Z, Xu X, Hsu HC, Tousson A, Yang PA, Wu Q, Liu C, Yu S, Zhang HG, Mountz JD: CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive T cells and CII-induced arthritis. J Clin Invest 112:1332–1341, 2003PubMedCrossRef
43.
Zurück zum Zitat Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maar C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593–2603, 1996PubMedCrossRef Fossiez F, Djossou O, Chomarat P, Flores-Romo L, Ait-Yahia S, Maar C, Pin JJ, Garrone P, Garcia E, Saeland S, Blanchard D, Gaillard C, Das Mahapatra B, Rouvier E, Golstein P, Banchereau J, Lebecque S: T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183:2593–2603, 1996PubMedCrossRef
44.
Zurück zum Zitat Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352, 1999PubMedCrossRef Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, Saito S, Inoue K, Kamatani N, Gillespie MT, Martin TJ, Suda T: IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 103:1345–1352, 1999PubMedCrossRef
45.
Zurück zum Zitat Kohem CL, Brezinscheck RI, Wisbey H, Tortorella C, Lipsky PE, Openheimer-Marks N: Enrichment of differentiated CD45Rbdim, CD27-memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 39:844–854, 1996PubMed Kohem CL, Brezinscheck RI, Wisbey H, Tortorella C, Lipsky PE, Openheimer-Marks N: Enrichment of differentiated CD45Rbdim, CD27-memory T cells in the peripheral blood, synovial fluid, and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum 39:844–854, 1996PubMed
46.
Zurück zum Zitat Szodoray P, Jellestad S, Nakken B, Brun JG, Jonsson R: Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Lab Invest 83:1839–1848, 2003PubMedCrossRef Szodoray P, Jellestad S, Nakken B, Brun JG, Jonsson R: Programmed cell death in rheumatoid arthritis peripheral blood T-cell subpopulations determined by laser scanning cytometry. Lab Invest 83:1839–1848, 2003PubMedCrossRef
47.
Zurück zum Zitat Goronzy JJ, Weyand CM: T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 16:212–217, 2004PubMedCrossRef Goronzy JJ, Weyand CM: T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 16:212–217, 2004PubMedCrossRef
48.
Zurück zum Zitat Namekawa T, Snyder MR, Yen JH, Goehring BE, Leibson PJ, Weyand CM, Goronzy JJ: Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 165:1138–1145, 2000PubMed Namekawa T, Snyder MR, Yen JH, Goehring BE, Leibson PJ, Weyand CM, Goronzy JJ: Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 165:1138–1145, 2000PubMed
49.
Zurück zum Zitat Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J Immunol 161:1018–1025, 1998PubMed Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ: Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28− T cells from rheumatoid arthritis patients. J Immunol 161:1018–1025, 1998PubMed
50.
Zurück zum Zitat Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, Hamann A, Radbruch A, Brauer R: The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 7:R291–301, 2005 Frey O, Petrow PK, Gajda M, Siegmund K, Huehn J, Scheffold A, Hamann A, Radbruch A, Brauer R: The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther 7:R291–301, 2005
51.
Zurück zum Zitat van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS: CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50:2775–2785, 2004PubMedCrossRef van Amelsfort JM, Jacobs KM, Bijlsma JW, Lafeber FP, Taams LS: CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50:2775–2785, 2004PubMedCrossRef
52.
Zurück zum Zitat Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277–285, 2004PubMedCrossRef Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277–285, 2004PubMedCrossRef
53.
Zurück zum Zitat de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B: CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435–6443, 2004PubMed de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B: CD4+CD25 bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172:6435–6443, 2004PubMed
54.
Zurück zum Zitat Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S: Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105:735–741, 2005PubMedCrossRef Balandina A, Lecart S, Dartevelle P, Saoudi A, Berrih-Aknin S: Functional defect of regulatory CD4+CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis. Blood 105:735–741, 2005PubMedCrossRef
55.
Zurück zum Zitat Goronzy JJ, Weyand CM: Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 22:251–255, 2001PubMedCrossRef Goronzy JJ, Weyand CM: Thymic function and peripheral T-cell homeostasis in rheumatoid arthritis. Trends Immunol 22:251–255, 2001PubMedCrossRef
56.
Zurück zum Zitat Wagner UG, Koetz K, Weyand CM, Goronzy JJ: Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 95:14447–14452, 1998PubMedCrossRef Wagner UG, Koetz K, Weyand CM, Goronzy JJ: Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA 95:14447–14452, 1998PubMedCrossRef
57.
Zurück zum Zitat Weyand CM, Goronzy JJ: T-cell responses in rheumatoid arthritis: Systemic abnormalities-local disease. Curr Opin Rheumatol 11:210–217, 1999PubMedCrossRef Weyand CM, Goronzy JJ: T-cell responses in rheumatoid arthritis: Systemic abnormalities-local disease. Curr Opin Rheumatol 11:210–217, 1999PubMedCrossRef
Metadaten
Titel
Rosmarinic Acid Induces Apoptosis of Activated T Cells from Rheumatoid Arthritis Patients via Mitochondrial Pathway
verfasst von
YUN-GYOUNG HUR
CHANG-HEE SUH
SUNGJOO KIM
JONGHWA WON
Publikationsdatum
01.01.2007
Erschienen in
Journal of Clinical Immunology / Ausgabe 1/2007
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-006-9057-8

Weitere Artikel der Ausgabe 1/2007

Journal of Clinical Immunology 1/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.